Keygraf 0.5 Capsule
By Keygraf
Rx
10 Capsule in a Strip
Composition
Tacrolimus(0.5mg)
Manufacturer - Anthem Biopharma
No 49, Canara Bank Road, Bommasandra Industrial Area, Phase 1, Hosur Road, Bangalore 560 099, Karnataka, India.
Expires on or after
July, 2025
When considering Keygraf 0.5 Capsule, it is important to be cautious if you have liver disease. Patients with liver conditions may require adjustment of the Keygraf 0.5 Capsule dosage. For individuals with liver diseases or conditions, it is strongly recommended to consult with a healthcare provider before initiating the use of Keygraf 0.5 Capsule.
Keygraf 0.5 Capsule requires caution in kidney disease patients. Adjusting the dose may be necessary. Consult your doctor, especially if you have kidney conditions, before using Keygraf 0.5 Capsule.
To ensure safety while taking Keygraf 0.5 Capsule, it is important to avoid alcohol consumption. Mixing alcohol with this medication can lead to increased risk of adverse effects. It is advisable to consult your doctor before drinking alcohol while using Keygraf 0.5 Capsule.
Keygraf 0.5 Capsule can reduce alertness, impact vision, and induce drowsiness or dizziness. Avoid driving if you experience these effects. Vision issues or nervous disturbances may occur in some individuals, so refrain from driving if such symptoms arise post-taking Tacrol 0.5 mg Capsule 10's.
Keygraf 0.5 Capsule may not be safe during pregnancy. Animal studies suggest potential harm to the developing baby. Consult your doctor for a thorough evaluation of benefits and risks before using this medication. If pregnant, be aware of possible kidney or neonatal hyperkalemia risks. Utilize effective contraception while taking Keygraf 0.5 Capsule.
Keygraf 0.5 Capsule may not be safe for breastfeeding as it can pass into breastmilk, potentially harming the baby. Inform your doctor if you are breastfeeding before taking this medication. It is advisable to avoid breastfeeding while using Keygraf 0.5 Capsule.
Habit Forming | No |
Chemical Class | Macrolide Lactams |
Therapeutic Class | - |
Action Class | Immunosuppressant- Calcineurin inhibitors |
₹231.35
Inclusive of all taxes
Content verified by
Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024